UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Cetera Investment Advisers

Cetera Investment Advisers cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 226,578 shares of the healthcare conglomerate's stock after selling 933 shares during the quarter. Cetera Investment Advisers' holdings in UnitedHealth Group were worth $114,617,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the stock. Western Pacific Wealth Management LP grew its position in shares of UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after buying an additional 19 shares during the period. MCF Advisors LLC grew its holdings in UnitedHealth Group by 0.8% during the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after acquiring an additional 20 shares during the period. Axiom Financial Strategies LLC lifted its stake in shares of UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock valued at $291,000 after purchasing an additional 20 shares during the period. Richwood Investment Advisors LLC grew its stake in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares during the period. Finally, Prentice Wealth Management LLC lifted its stake in UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock valued at $1,278,000 after buying an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $404.81 on Tuesday. The stock's fifty day moving average price is $494.68 and its two-hundred day moving average price is $527.03. The firm has a market cap of $368.47 billion, a price-to-earnings ratio of 26.12, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $393.11 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the firm earned $6.91 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.08%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is currently 35.18%.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. KeyCorp cut their price target on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Raymond James reiterated a "strong-buy" rating and set a $540.00 target price (down from $635.00) on shares of UnitedHealth Group in a report on Monday, April 21st. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Finally, Hsbc Global Res cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 22nd. Four analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.